Mark A. Findeis
- Molecular Biology top 10%
- Physiology top 5%
- Pharmacology top 5%
- Computational Theory and Mathematics top 5%
- Organic Chemistry top 10%
- Co-authors
- E. T. KaiserSusan M. MolineauxTimothy D. McKeeTomikazu SasakiGeorge M. WhitesidesJames WakefieldMichael S. P. KelleyGeorge Y. Wu
- Topics
- Alzheimer's disease research and treatments (9 papers)Immunotherapy and Immune Responses (5 papers)Chemical Synthesis and Analysis (5 papers)
- Cited by
- PhysiologyPharmacologyBiomaterials
- Partner nations
- United StatesNetherlandsNorway
In The Last Decade
Mark A. Findeis
34 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 716
- Physiology 596
- Pharmacology 232
- Computational Theory and Mathematics 190
- Organic Chemistry 176
Countries citing papers authored by Mark A. Findeis
This map shows the geographic impact of Mark A. Findeis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Findeis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Findeis more than expected).
Fields of papers citing papers by Mark A. Findeis
This network shows the impact of papers produced by Mark A. Findeis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Findeis. The network helps show where Mark A. Findeis may publish in the future.
Co-authorship network of co-authors of Mark A. Findeis
This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Findeis. A scholar is included among the top collaborators of Mark A. Findeis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Findeis. Mark A. Findeis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 6 | |
| 3 | 14 | |
| 4 | 22 | |
| 5 | 3 | |
| 6 | 8 | |
| 7 | 261 | |
| 8 | 71 | |
| 9 | 23 | |
| 10 | 152 | |
| 11 | 19 | |
| 12 | 23 | |
| 13 | 73 | |
| 14 | 18 | |
| 15 | 22 | |
| 16 | 38 | |
| 17 | 15 | |
| 18 | 35 | |
| 19 | 4 | |
| 20 | 10 |
About Mark A. Findeis
Mark A. Findeis is a scholar working on Physiology, Molecular Biology and Immunology, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (9 papers), Immunotherapy and Immune Responses (5 papers) and Chemical Synthesis and Analysis (5 papers). The work is most often cited by research in Physiology (596 citations), Pharmacology (232 citations) and Biomaterials (171 citations). Mark A. Findeis has collaborated with scholars based in United States, Netherlands and Norway. Frequent co-authors include E. T. Kaiser, Susan M. Molineaux, Timothy D. McKee, Tomikazu Sasaki, George M. Whitesides, James Wakefield, Michael S. P. Kelley, George Y. Wu, Mary DeRome and Howard W. Benjamin. Their work appears in journals such as Science, Journal of the American Chemical Society and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.